Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,976 | 35,385 | 18,548 | 23,867 | 10,716 |
| TOTAL | $29,589 | $36,006 | $19,129 | $24,420 | $11,402 |
| Non-Current Assets | |||||
| PPE Net | 4 | 5 | 7 | 10 | 12 |
| Other Non-Current Assets | 95 | 86 | 80 | 81 | 206 |
| TOTAL | $99 | $91 | $87 | $91 | $218 |
| Total Assets | $29,688 | $36,097 | $19,216 | $24,511 | $11,620 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,677 | 1,173 | 1,023 | 1,270 | 892 |
| Accrued Expenses | 1,064 | 1,342 | 917 | 919 | 1,169 |
| Other current liabilities | N/A | N/A | N/A | 224 | N/A |
| TOTAL | $2,993 | $2,859 | $2,143 | $2,419 | $2,358 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,993 | $2,859 | $2,143 | $2,419 | $2,358 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,383 | 72,031 | 67,031 | 62,704 | 62,475 |
| Common Shares | 72 | 72 | 63 | 62 | 50 |
| Retained earnings | -169,111 | -162,006 | -156,311 | -150,238 | -145,068 |
| Other shareholders' equity | -97 | -97 | -97 | -101 | -101 |
| TOTAL | $26,695 | $33,238 | $17,073 | $22,092 | $9,262 |
| Total Liabilities And Equity | $29,688 | $36,097 | $19,216 | $24,511 | $11,620 |